Controlled-release Drug Delivery Technologies: Players, products & prospects to 2015

Table of Contents

EXECUTIVE SUMMARY

• Competitor Ratio Analysis Summary

Introduction

Overview of controlled-re lease delivery : past , present & future

• Controlled-Release delivery: motivators & resistors
  • Motivators
  • Resistors
• Controlled-Release delivery: impact on product lifecycles

CONTROLED-RELEASE DELIVERY

• Types of controlled-release delivery used by pharma industry
  • Activated controlled-release delivery
    • Figure 1: Activated controlled-release delivery - ALZA' s OROS systems
  • Degradation controlled-release delivery
    • Figure 2: Degradation controlled-release delivery - SkyePharma' s GEOMATRIX
  • Diffusion controlled-release delivery
    • Figure 3: Monolithic diffusion controlled-release delivery - LaboPharm' s Contramid
    • Figure 4: Reservoir diffusion controlled-release delivery - Impax' CMDS
    • Figure 5: Combined controlled-release delivery - Flamel' s Micropump
    • Table 1: Advantages and disadvantages of controlled-release platforms
• Current therapeutic application of controlled-release in drug delivery
• Leading brands that utilise controlled-release delivery
  • Table 2: Controlled-Release approved drugs
• Future commercial applications & opportunities

STRATEGIES OF DRUG DELIVERY COMPANIES

• Leading controlled-release drug delivery companies
  • Table 3: Leading controlled-release drug delivery companies
• Partnerships & acquisitions
  • Strategic developmental & commercialisation partnerships
  • Merger & acquisitions
    • Table 4: Recent partnerships & acquisitions in the controlled-release field
• Intellectual Property
  • Table 5: Controlled-Release patents
• THE controlLed-release MARKET
  • Now 2007
    • Table 6: Approved controlled-release product sales
  • Future 2015
    • Table 7: Global controlled-release product sales
    • Table 8: Novel controlled-release product sales

COMPETITOR ANALYSIS

• Movers & Shakers: Cutting edge or losing their grip
  • Table 9: Movers & shakers in controlled-release drug delivery systems

COMPANY PROFILES

• AlphaRx Corporation
  • Table 10: AlphaRx' product pipeline
  • Table 11: AlphaRx' drug delivery sales
• ALZA Corporation
  • Table 12: ALZA' s product pipeline
  • Table 13: ALZA' s drug delivery sales
• Andrx Corporation
  • Table 14: Andrx' product pipeline
  • Table 15: Andrx' drug delivery sales
• Antares Pharma, Inc.
  • Table 16: Antares' product pipeline
  • Table 17: Antares' drug delivery sales
• Biovail International
  • Table 18: Biovail' s product pipeline
  • Table 19: Biovail' s drug delivery sales
• Camurus AB
  • Table 20: Camurus AB' s product pipeline
  • Table 21: Camurus AB' s drug delivery sales
• Cipher Pharmaceuticals, Inc.
  • Table 22: Cipher' s product pipeline
  • Table 23: Cipher' s drug delivery sales
• Debiopharm
  • Table 24: Debiopharm' s product pipeline
  • Table 25: DebioPharm' s drug delivery sales
• DelSite Biotechnologies, Inc.
  • Table 26: DelSite' s product pipeline
• Depomed, Inc.
  • Table 27: Depomed' s product pipeline
  • Table 28: Depomed' s product sales
• Durect Corporation
  • Table 29: Durect' s product pipeline
  • Table 30: Durect' s product sales
• Eiffel Technologies
  • Table 31: Eiffel' s product pipeline
• Elan Corporation
  • Table 32: Elan' s product pipeline
  • Table 33: Elan' s drug delivery sales
• Elite Pharmaceuticals, Inc.
  • Table 34: Elite' s product pipeline
  • Table 35: Elite' s product sales
• Endo Pharmaceuticals, Inc.
  • Table 36: Endo' s product pipeline
  • Table 37: Endo' s product sales
• Ethypharm SA
  • Table 38: Ethypharm' s product pipeline
  • Table 39: Ethypharm' s product sales
• Eurand
  • Table 40: Eurand' s product pipeline
  • Table 41: Eurand' s product sales
• Flamel Technologies, Inc.
  • Table 42: Flamel' s product pipeline
  • Table 43: Flamel' s product sales
• Glycologic, Ltd
  • Table 44: Glycologic' s product pipeline
• Impax Laboratories, Inc.
  • Table 45: Impax' product pipeline
  • Table 46: Impax' s product sales
• KV Pharmaceuticals, Inc
  • Table 47: KV' s product pipeline
• Labopharm, Inc.
  • Table 48: Labopharm' s product pipeline
  • Table 49: Labopharm' s product sales
• Lavipharm SA
  • Table 50: Lavipharm' s product pipeline
  • Table 51: Lavipharm' s product sales
• OctoPlus N.V.
  • Table 52: Octoplus' product pipeline
  • Table 53: Octoplus' product sales
• Penwest Pharmaceuticals
  • Table 54: Penwest' s product pipeline
  • Table 55: Penwest' s product sales
• Protherics
  • Table 56: Protherics' product pipeline
  • Table 57: Protherics' drug delivery sales
• SCOL R Pharma, Inc.
  • Table 58: SCOLR' s product pipeline
  • Table 59: SCOLR' s drug delivery sales
• Shire
  • Table 60: Shire' s product pipeline
  • Table 61: Shire' s drug delivery sales
• Skinvisible, Inc.
  • Table 62: Skinvisible' s product pipeline
• SkyePharma
  • Table 63: SkyePharma' s CR product pipeline
  • Table 64: SkyePharma' s controlled-release product sales
• Spherics
  • Table 65: Spheric' s product pipeline

APPENDIX 1

• Table 66: Global controlled-release approved drugs sales 2006A-20015E

APPENDIX 2

• Table 67: Global controlled-release developmental drugs sales 2006A-20015E

APPENDIX 3

• Competitor Ratio Analysis Criteria
  • Table 68: Key Controlled-Release delivery companies by 2015

BIBLIOGRAPHY

GLOSSARY

ACRONYMS